CStone Pharmaceuticals (HKG:2616)
Hong Kong · Delayed Price · Currency is HKD 8.92
+0.04 (0.45%)
Aug 19, 2025, 11:45 AM HKT
CStone Pharmaceuticals Market Cap
CStone Pharmaceuticals has a market cap or net worth of 13.01 billion as of August 18, 2025. Its market cap has increased by 757.05% in one year.
Market Cap
13.01B
Enterprise Value
12.68B
Revenue
221.89M
Ranking
n/a
PE Ratio
n/a
Stock Price
8.92
Market Cap Chart
Since February 26, 2019, CStone Pharmaceuticals's market cap has increased from 12.65B to 13.01B, an increase of 2.78%. That is a compound annual growth rate of 0.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 18, 2025 | 13.01B | 343.03% |
| Dec 31, 2024 | 2.94B | 1.52% |
| Dec 29, 2023 | 2.89B | -47.58% |
| Dec 30, 2022 | 5.52B | -42.71% |
| Dec 31, 2021 | 9.63B | -16.96% |
| Dec 31, 2020 | 11.60B | 11.17% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 26, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines | 276.65B |
| Hansoh Pharmaceutical Group Company | 221.78B |
| JD Health International | 196.01B |
| Innovent Biologics | 166.99B |
| Akeso | 148.55B |
| Sino Biopharmaceutical | 139.86B |
| WuXi Biologics | 125.94B |
| CSPC Pharmaceutical Group | 125.31B |